Podcasts about hiv prevention

Clarence Ford spoke to Belinda Thibela, health GAP International policy and advocacy co-ordinator Views and News with Clarence Ford is the mid-morning show on CapeTalk. This 3-hour long programme shares and reflects a broad array of perspectives. It is inspirational, passionate and positive. Host Clarence Ford’s gentle curiosity and dapper demeanour leave listeners feeling motivated and empowered. Known for his love of jazz and golf, Clarrie covers a range of themes including relationships, heritage and philosophy. Popular segments include Barbs’ Wire at 9:30am (Mon-Thurs) and The Naked Scientist at 9:30 on Fridays. Thank you for listening to a podcast from Views & News with Clarence Ford Listen live on Primedia+ weekdays between 09:00 and 12:00 (SA Time) to Views and News with Clarence Ford broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/erjiQj2 or find all the catch-up podcasts here https://buff.ly/BdpaXRn Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

Catch Up on the latest leading news stories around the country with Mandy Wiener on Midday Report from 12:00 to 13:00See omnystudio.com/listener for privacy information.

Mandy Wiener speaks to founder and editor-in-chief of the Bhekisisa Centre for Health Journalism, Mia Malan about the Lenacapavir HIV prevention injection that being launched by President Ramaphosa for roll out across the country The Midday Report with Mandy Wiener is 702 and CapeTalk’s flagship news show, your hour of essential news radio. The show is podcasted every weekday, allowing you to catch up with a 60-minute weekday wrap of the day's main news. It's packed with fast-paced interviews with the day’s newsmakers, as well as those who can make sense of the news and explain what's happening in your world. All the interviews are podcasted for you to catch up and listen to. Thank you for listening to this podcast of The Midday Report Listen live on weekdays between 12:00 and 13:00 (SA Time) to The Midday Report broadcast on 702 https://buff.ly/gk3y0Kj and on CapeTalk https://buff.ly/NnFM3Nk For more from The Midday Report, go to https://buff.ly/BTGmL9H and find all the catch-up podcasts here https://buff.ly/LcbDdFI Subscribe to the 702 and CapeTalk daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

President Cyril Ramaphosa will today launch a new twice-a-year HIV prevention injection in Mpumalanga. The shot offers six months of protection per dose and will be rolled out nationally. Health officials say it could transform prevention efforts in high-risk areas. The rollout starts today at an event in Mpumalanga. Authorities hope the injectable will reduce new infections nationwide. We spoke to Sibongile Tshabalala, Chairperson of the Treatment Action Campaign

Thabo Shole-Mashao speaks to Prof Linda-Gail Bekker, Director at the Desmond Tutu Health Foundation, about the rollout of the long-acting HIV prevention injection lenacapavir, its potential to reduce new infections, and what it means for South Africa’s fight against HIV. Early Breakfast with Africa Melane is 702’s and CapeTalk’s early morning talk show. Experienced broadcaster Africa Melane brings you the early morning news, sports, business, and interviews politicians and analysts to help make sense of the world. He also enjoys chatting to guests in the lifestyle sphere and the Arts. All the interviews are podcasted for you to catch-up and listen. Thank you for listening to this podcast from Early Breakfast with Africa Melane For more about the show click https://buff.ly/XHry7eQ and find all the catch-up podcasts here https://buff.ly/XJ10LBU Listen live on weekdays between 04:00 and 06:00 (SA Time) to the Early Breakfast with Africa Melane broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3N Subscribe to the 702 and CapeTalk daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Africa Melane speaks to Prof Brendan Maughan-Brown, Chief Research Officer and Associate Professor at the University of Cape Town’s SALDRU, about the rollout of the new HIV prevention injection LEN and efforts to combat misinformation before it spreads online.See omnystudio.com/listener for privacy information.

In this episode of Tiny Show and Tell Us, we welcome our first‑ever guest, podcast producer and dinosaur enthusiast Steven Ray Morris. Together, we dive into three wildly different stories. First, we explore a major advancement in HIV prevention: a newly approved twice‑yearly injectable drug called Lenacapavir. We chat about how it works, why it's a huge shift from daily pills or monthly shots, and the challenges around global access. Next, Steven takes us deep into the (mostly chilly) past — to Antarctic dinosaurs! What scientists are learning about these dinos is shifting what we think we know about where, and how, dinosaurs lived. Finally, Deboki breaks down the science behind blood flow restriction therapy, a rehabilitation technique that helps injured muscles rebuild strength using lighter loads. As always, Tiny Matters is not giving anything that could be interpreted as medical advice! Deboki also reveals she's into weightlifting. So yeah, don't mess with Deboki! You can find Steven and See Jurassic Right lots of places! Including Instagram, Apple Podcasts, Patreon and Etsy.Check out Spirits here or wherever you get podcasts!We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Un nouvel épisode du Pharmascope est disponible! Dans ce 176e épisode, Nicolas, Olivier et Amélie discutent de VIH et de PrEP injectable.  Les objectifs pour cet épisode sont les suivants: Identifier les patients pouvant bénéficier de la PrEP Discuter des avantages et des désavantages du cabotégravir Discuter des avantages et des désavantages associés du lénacapavir Ressources pertinentes en lien avec l'épisode Baril JG et coll. La prophylaxie préexposition au virus de l'immunodéficience humaine : Guide pour les professionnels de la santé du Québec. Ministère de la santé et des services sociaux. Janvier 2019. Monographie de produit. Apretude (cabotégravir). Canada. 10 mai 2024. Landovitz RJ, et coll; HPTN 083 Study Team. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021 Aug 12;385(7):595-608. Delany-Moretlwe S, et coll; HPTN 084 study group. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022 May 7;399(10337):1779-1789. Monographie de produit. Yeztugo (lenacapavir). USA. 06/2025. Bekker LG, et coll; PURPOSE 1 Study Team. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. N Engl J Med. 2024 Oct 3;391(13):1179-1192. Kelley CF, et coll; PURPOSE 2 Study Team. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. N Engl J Med. 2025 Apr 3;392(13):1261-1276.

How does an organization successfully cultivate a group of ambassadors to maximize attendance, revenue, and impact? Today, I talk with Rhiannon Bolen, Board Chair for DIFFA Dallas to talk about the organization's annual signature fundraising event, House of DIFFA. Texas's answer to the Met Gala, each year House of DIFFA is an evening of impact with a dash of fantasty, created through the legendary themes, with this year's being Hotel Mystique. The event draws over 1,000 top patrons, activists, and community leaders who are on hand to raise funds that provide grants for HIV Prevention as well as programs to support those living with HIV/AIDS. One way the organization does this is through an innovative group of individuals called the DIFFA Style Council Ambassadors. Each year a group of 12-15 community leaders who possess great style help increase awareness and attendance, resulting in one of the most fun fundraising events in the country. Rhiannon provides valuable insights on a range of topics, including tips on creating an innovative theme that resonates with your audience...and attracting new donors, creating a memorable silent auction that fuses creativity, community and fundraising, successfully getting high-profile individuals to support your event, and so much more. This is one episode you will definitely not want to miss.

Director of Technical Services at the Ghana AIDS Commission, Fred Nana Poku, has warned that rising condom prices could discourage public use and potentially increase HIV transmission in Ghana

Michael Scarce worked at a now-defunct nonprofit called the Stop AIDS Project till in 2007, he blew the whistle when it began suggesting that to end AIDS, we need to "prevent sexual mixing." Michael's Substack: 'A Parable of Second-Hand Sodomy: Lessons Learned From San Francisco's Failed Attempt at Viral Apartheid in the Name of HIV Prevention' https://gettingbeyondzero.substack.com/p/a-parable-of-second-hand-sodomy-lessons Center for HIV Law and Policy's project against HIV surveillance https://www.hivlawandpolicy.org/basic

The conversation delves into the publication 'Reasons Over Risks, NPs and HIV Prevention for Black Women' and explores the met needs, reframing risk and language in healthcare spaces, findings and impact of the work, the importance of caring and taking action, equipping providers and initiating conversations, and the passion for the work and advice for new researchers.TakeawaysHIV prevention for Black womenReframing risk and sexual health conversationsJoin us as we explore the urgent need for clinicians to address the biases surrounding Black women's health. Our latest episode sheds light on the critical research that aims to change the narrative around HIV prevention.

The South African National AIDS Council, SANAC has welcomed the arrival of the ground-breaking HIV prevention drug, lenacapavir. The twice-yearly injectable is said to be a game-changer in HIV prevention, particularly for high-burden countries like South Africa. SANAC is pushing for local manufacturing to enhance sustainability and affordability. Elvis Presslin spoke to Gertrude Mngola, Health Products Grant Specialist at the South African National AIDS Council (SANAC)

First batch of HIV prevention drug arrives in SA after 6-week delay by Radio Islam

On the Feb 13th edition: Residents of the city of Social Circle say they're not happy about plans for a new ICE detention facility; Georgia lawmakers pass legislation to boost access to H-I-V prevention medication; And to make housing in Georgia more affordable, some lawmakers say they need to level the playing field.

Broadcast from KSQD, Santa Cruz on 1-01-2025: An emailer asks about omega-3 supplementation for memory at age 72. Dr. Dawn advises checking that fish oil capsules contain adequate DHA—at least 1,000 mg—since many omega-3 products have low DHA levels. She notes Medicare covers the same testing at standard labs as proprietary labs like OmegaQuant that charge patients directly. Beyond omega-3s, she emphasizes glucose control (hemoglobin A1c below 5.6) since the enzyme that breaks down insulin also clears beta-amyloid, and weight training to raise brain-derived neurotrophic factor (BDNF), which promotes new synapse formation essential for memory. Dr. Dawn reviews Popular Science's top 2025 health innovation: eye drops from Lens Therapeutics containing aceclidine that correct age-related farsightedness for 10 hours. The drops shrink the pupil to increase depth of field, improving near vision by three or more lines on eye charts within 30 minutes without affecting distance vision. Side effects include eye irritation, dimmed night vision, and headache. She describes Duke University's breakthrough allowing heart transplants from circulatory death donors using an on-table reanimation technique. This could expand the pediatric donor pool by 20%—critical since up to 20% of children die waiting for transplants. Dr. Dawn celebrates CAR-T immunotherapy for multiple myeloma, which saved her husband's life. Of 97 heavily pretreated patients, 38% achieved complete remission still present at five years, with over 50% total survival. The therapy removes T-cells, uses CRISPR to add receptors targeting cancer cell antigens, then reinfuses the modified cells. She highlights a UC Davis study showing remote blood pressure monitoring with home technology, education, and coaching dropped patients' average blood pressure from 150/80 to 125/74 in months—low-tech with high impact. Dr. Dawn explains the Nano Knife for prostate cancer, which uses localized electrical pulses delivered through thin wires to destroy tumors while sparing surrounding nerves. This minimally invasive approach could reduce erectile dysfunction and incontinence common with traditional surgery. She describes Gilead's Sunlenca, a twice-yearly injection for HIV prevention that's 99% effective. At $14,000 per injection in the US, proceeds help fund access in resource-limited countries where it can be distributed like a vaccination. Dr. Dawn discusses Journavx (suzetrigine), a new non-opioid pain medication working on sodium channels to block pain signals before reaching the brain. At $30 for 50 pills on GoodRx, it offers an alternative for surgical pain in patients with addiction history or genetic vulnerability to opioid dependence. She details the landmark case of Baby KJ, the first person to receive personalized CRISPR gene therapy. Born with a CPS1 enzyme deficiency causing toxic ammonia buildup, KJ was too small for liver transplant. Scientists identified his specific mutation and used CRISPR base editing delivered via lipid nanoparticles to correct a single DNA letter—changing an A to G—in his liver cells which restored enough function to be discharged home. Dr. Dawn reports surprising findings that COVID mRNA vaccines amplify cancer immunotherapy. Lung cancer patients who received COVID vaccination within 100 days of checkpoint inhibitor treatment had 56% three-year survival versus 31% for unvaccinated patients. The mechanism is unknown but may involve mRNA generally alerting the immune system. She revisits research showing Zostavax shingles vaccination reduced dementia risk by 20% over seven years. A natural experiment in Wales—where an age cutoff created comparable vaccinated and unvaccinated groups—provided strong evidence that preventing herpes zoster inflammation protects brain health. Dr. Dawn concludes with Huntington's disease breakthrough: microRNA therapy delivered by virus directly into the brain slowed disease progression by 75% over three years. The microRNA binds to Huntington protein mRNA, preventing ribosome translation and toxic protein production. Some patients returned to work; others expected to need wheelchairs are still walking.

RaeAnn Tucker joined Wake Up Tri-Counties to talk about resolutions, reproductive health, HIV prevention, insurance navigators, flu and COVID-19 vaccines, and gun locks. The Henry and Stark County Health Departments are doubling down on their commitment to community wellness in 2026 with a range of initiatives. Residents can access free and confidential HIV prevention services, including testing, education, and medication support through the PrEP/HIV Prevention program at First Choice Healthcare Clinics in Kewanee and Toulon. In a push for safety, free gun locks aimed at preventing firearm injuries are available weekdays at multiple locations. For those navigating health insurance, the Get Covered Illinois Navigator Program offers personalized assistance at upcoming local events. Visit henrystarkhealth.com or follow their social media for updates and resources.

Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series.Together they discuss withstanding external funding shocks, meaningful community involvement, and focusing on health equity, as part of a sustainable approach to HIV prevention in Africa.Click here to read the full series: https://www.thelancet.com/series-do/sustainable-hiv-prevention-africaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series.Together they discuss withstanding external funding shocks, meaningful community involvement, and focusing on health equity, as part of a sustainable approach to HIV prevention in Africa.Click here to read the full series: https://www.thelancet.com/series-do/sustainable-hiv-prevention-africaContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

In the first episode of the Prevention Intention mini-series, a series featuring conversations with leading female HIV clinical researchers, Katherine speaks with Linda-Gail Bekker, a medical doctor and director of the Desmond Tutu HIV Centre at the University of Cape Town.  They discuss Bekker's decision to focus her work on HIV as well as her involvement in the PURPOSE 1 clinical trials, which demonstrated the efficacy of long-acting pre-exposure prophylaxis (PrEP) among adolescent girls and young women in South Africa and Uganda. They also cover why it's important to approach research as a highly collaborative endeavor that both contributes to scientific understanding and improves people's lives.

On World AIDS Day, Pratik Pawar, Future Perfect fellow at Vox, talks about a new HIV prevention drug the U.S. is making available everywhere except South Africa, the country with the most people living with HIV. 

Communities across the globe commemorated World AIDS Day, reaffirming a commitment to end an epidemic that has killed more than 44 million. But this year, for the first time in decades, the U.S. government decided not to mark the occasion, and the Trump Administration has reportedly barred agencies from commemorating or participating. William Brangham discussed more with Dr. Demetre Daskalakis. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

For World Aids Day 2025, Yo Aunteas sit with Mario Harper, Director at Health Action Alliance and leader of the U.S. Business Action to End HIV, to discuss a topic too often shrouded in shame: HIV in the Black Community. Mario shares his deeply personal journey, from overcoming family stigma surrounding his uncle's death to leading national efforts to secure critical funding for grassroots HIV services. This episode is about courage, visibility, and reclaiming our narrative. We break down: How the HIV funding crisis directly impacts Black and Latinx lives. The power of confronting family and church stigma. Why queer people of color are embracing words like "sissy" to embody their whole truth. This is a powerful, educational, and necessary episode. Don't just listen—share this with your entire Communitea! Of course, we end with Curiositea! Subscribe now to the Minoritea Report for more unfiltered Black queer perspectives and get them cups ready! Tea Stamps: 00:00 Intro 01:03 Thanksgiving: Black Olympics 06:24 Mario Harper's Background 12:48 Sissy That Walk 16:14 World AIDS Day: The Role Of Visibility and Funding 22:56 The Future of HIV Services and Community Support 26:25 Economic Impact and Community Health 27:11 Barriers to Healthcare Access 29:07 Stigma and the Black Church 31:16 Corporate Responsibility in HIV Awareness 35:33 Engaging Younger Generations 40:01 Innovations in HIV Prevention 43:34 Media Representation and HIV Awareness 47:31 Get Tested! 49:59 Q Care Plus & Mistr: Avenues for PREP 52:06 Reflections on Wicked: For Good 01:03:03 The Boy Is Mine Tour: Brandy & Monica 01:07:15 Curiositea: Mario Harper 01:11:49 What Do You Know For Sure? 01:13:04 Beyoncé vs. Janet 01:14:51 Benediction

Communities across the globe commemorated World AIDS Day, reaffirming a commitment to end an epidemic that has killed more than 44 million. But this year, for the first time in decades, the U.S. government decided not to mark the occasion, and the Trump administration has reportedly barred agencies from commemorating or participating. William Brangham discussed more with Dr. Demetre Daskalakis. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Communities across the globe commemorated World AIDS Day, reaffirming a commitment to end an epidemic that has killed more than 44 million. But this year, for the first time in decades, the U.S. government decided not to mark the occasion, and the Trump administration has reportedly barred agencies from commemorating or participating. William Brangham discussed more with Dr. Demetre Daskalakis. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

It is a momentous occasion when Judson wears an entirely black outfit. Brian takes his family to the fantastic new revival of The 25th Annual Putnam County Spelling Bee off-Broadway, where his daughter joins the cast for the afternoon. Judson crowdsources an internship for a new friend he met by chance over ramen. The Hookup of the Week comes from a sub who finds a deeper connection with one of his regular Doms. The two are then joined by Dr. Demetre Daskalakis, former director of the CDC's National Center for Immunization and Respiratory Diseases before his fiery resignation this summer. Having also served as the CDC's Director of HIV Prevention, the White House's Deputy Coordinator of the National Monkeypox Response in 2022-2023, and the Deputy Commissioner of NYC's Department of Health, Dr. Daskalakis brings an incredible wealth of knowledge, experience, stories and sexy Daddy energy to the Dads and Daddies studio. Dr. Demetre speaks with Brian and Judson about his resignation from the CDC this summer and the hostile takeover of the organization by RFK Jr., being dubbed “Dr. Daddy” by legendary nightlife impresario Susanne Bartsch, his days on the front lines testing for HIV in NYC's bathhouses and sex clubs, the origin and evolution of his 14-year relationship with his husband Michael, their imminent move back to New York, the meaning behind his tattoos, the love of Madonna concerts he shares with Brian, and his intolerance of bullies instilled by his father that has made him the fighter he is today. He then joins Brian and Judson for a mini Go Ask Your Dad Extravaganza, tackling three listener-submitted questions about communicating when one tests positive for an STI, conquering a debilitating fear of HIV, and handling the discovery of an open sore during an anonymous sex encounter. Find Dr. Demetre Daskalakis on Instagram at https://www.instagram.com/drdemetre and on Bluesky at https://bsky.app/profile/drdemetre.bsky.social Email your Hookup of the Week and Go Ask Your Dad submissions to dadsanddaddies@gmail.com Dads and Daddies on the Web: https://www.dadsanddaddies.com/ Dads and Daddies on Instagram: https://www.instagram.com/dadsanddaddiespod Dads and Daddies on TikTok: https://www.tiktok.com/@dadsanddaddiespod Dads and Daddies on Bluesky: https://bsky.app/profile/dadsanddaddiespod.bsky.social Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations. Topics covered include:PrEP candidacy Selection of individualized regimensKey barriers to PrEP useStrategies for overcoming key barriers to PrEP accessEvolving state-based legislation on PrEP provision by pharmacistsModels of pharmacy-managed PrEPStrategies for addressing inequities in PrEP careComprehensive HIV prevention servicesPresenters:Tessa Rife-Pennington, PharmD, BCGPDr. Dawn K. Smith HIV Prevention Clinical FellowAmerican Academy of HIV MedicineVolunteer Assistant Clinical ProfessorUniversity of California, San Francisco, School of PharmacySan Francisco, CaliforniaFrank North, PharmD, MPA, DPLA, DASPLInstructional Assistant Professor, Irma Lerma Rangel College of PharmacyDirector of Learning in PracticeOffice of Interprofessional Practice, Education and ResearchTexas A&M University Health Science CenterPast President, National Pharmaceutical AssociationCollege Station, TexasLink to full program: https://bit.ly/49SLc0yGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Overview: In this episode, Toyin Nwafor, MD, and Christian B Ramers, MD, draw on their experience in primary care, HIV and HIV prevention to highlight missed opportunities for HIV prevention and discuss strategies to help address gaps in the HIV care continuum. The views expressed are those of the panelist(s) and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2025 and the content reflects the information available at that time. Guest: Toyin Nwafor, MD; Christian B Ramers, MD, MPH, FIDSA, AAHIVS   For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus  References AIDSVu.org. Prevalence in the United States. 2022. Available from: https://map.aidsvu.org/ (Accessed June 25, 2025). AIDSVu.org was developed by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc. Baeten J et al. Curr HIV/AIDS Rep 2013;10:142–51. CDC. Clinical testing guidance for HIV. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/diagnosis-testing/index.html (Accessed June 25, 2025). CDC. Discussing sexual health with your patients. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/sexual-history/index.html (Accessed June 25, 2025). CDC.gov. HIV diagnoses, deaths, and prevalence. 2025. Available from: https://www.cdc.gov/hiv-data/nhss/hiv-diagnoses-deaths-prevalence.html (Accessed June 25, 2025). CDC. National HIV prevention and care objectives: 2025 update. 2025. Available from: https://www.cdc.gov/hiv-data/nhss/national-hiv-prevention-and-care-objectives-2025.html (Accessed June 25, 2025). CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2021 update: a clinical practice guideline. 2021. Available from: https://stacks.cdc.gov/view/cdc/112360 (Accessed June 25, 2025). Doblecki-Lewis S et al. J Int Assoc Provid AIDS Care 2019;18:2325958219848848. DHHS. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf (Accessed June 25, 2025). HIV.gov. Key EHE strategies. 2024. Available from: https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/key-strategies (Accessed June 2, 2025). HIV.gov. HIV treatment as prevention. 2023. Available from: https://www.hiv.gov/tasp (Accessed June 25, 2025). HIV.gov. US statistics. 2025. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics (Accessed May 21, 2025). HIV.gov. Viral suppression and undetectable viral load. 2025. Available from: https://www.hiv.gov/hiv-basics/staying-in-hiv-care/hiv-treatment/viral-suppression (Accessed July 18, 2025). HIV.gov. Who is at risk for HIV. 2025. Available from: https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/who-is-at-risk-for-hiv (Accessed June 25, 2025). Johns Hopkins Bloomberg School of Public Health. What to know about PrEP. 2025. Available from: https://publichealth.jhu.edu/2025/who-needs-prep-for-hiv-prevention (Accessed June 25, 2025). Kamis KF et al. Open Forum Infect Dis 2019;6:ofz310. KFF. HIV testing in the United States. 2024. Available from: https://www.kff.org/hiv-aids/hiv-testing-in-the-united-states/ting in the United States | KFF (Accessed August 26, 2025). NIH. HIV and sexually transmitted infections (STIs). 2021. Available from: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-sexually-transmitted-infections-stis (Accessed June 25, 2025). Ramchandani MS et al. Curr HIV/AIDS Rep 2019;16:244–56. Saag MS et al. JAMA 2018;320:379–96. Sweeney P et al. J Acquir Immune Defic Syndr 2019;82(Suppl 1):S1–5. The White House. National HIV/AIDS strategy for the United States 2022–2025. 2021. Available from: https://files.hiv.gov/s3fs-public/NHAS-2022-2025.pdf (Accessed June 25, 2025). UNAIDS.org. Recommended 2030 targets for HIV. 2025. Available from: https://www.unaids.org/en/recommended-2030-targets-for-hiv (Accessed August 26, 2025). United States Census Bureau. National population by characteristics: 2020-2024. 2024. Available from: https://www.census.gov/data/tables/time-series/demo/popest/2020s-national-detail.html (Accessed June 25, 2025). United States Census Bureau. United States Population Growth by Region. 2025. Available from: https://www.census.gov/popclock/ (Accessed June 25, 2025). Yumori C et al. Sex Transm Dis 2021;48:32–6.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of fascinating advancements and strategic movements that are shaping the landscape of drug development and patient care.Starting with a significant milestone in precision oncology, China has approved its first EGFR-targeted antibody-drug conjugate. This approval marks a pivotal moment in the industry's shift towards targeted therapies, which promise more precise treatment options with potentially fewer side effects than traditional chemotherapy. Targeted therapies are at the forefront of personalized medicine, where treatments are tailored to individual genetic profiles, offering hope for more effective cancer care.In the realm of HIV prevention, Gilead Sciences has reported impressive sales for its new long-acting pre-exposure prophylaxis medication, Yetztugo. Since its launch in June 2025, Yetztugo has generated $54 million in U.S. sales, underscoring the demand for long-term HIV prevention solutions. This development is part of Gilead's broader strategy to strengthen its HIV franchise as it advances its pipeline with promising candidates like GS-3242 alongside lenacapavir. The aim is to develop treatments that require less frequent dosing, which could significantly improve patient adherence and outcomes. Despite challenges within its HIV portfolio and declining Veklury sales, Gilead Sciences is actively seeking growth opportunities through strategic partnerships and pipeline advancements—an essential approach for navigating patent cliffs while sustaining long-term growth.On the financial front, AbbVie has increased its revenue forecast by $400 million to a staggering $60.9 billion, driven by robust sales from its immunology drugs Skyrizi and Rinvoq. These treatments address chronic inflammatory conditions like psoriasis and rheumatoid arthritis, reflecting AbbVie's strong positioning in this therapeutic area despite competitive pressures. AbbVie continues to report strong earnings from Skyrizi and Rinvoq, reinforcing its dominance in the immunology market and highlighting the profitable nature of successful biologics in treating chronic inflammatory diseases.Biogen continues to bolster its multiple sclerosis franchise by focusing on both legacy treatments and new product launches. This strategy highlights the importance of balancing innovation with lifecycle management to maintain market strength against generic competition—a common challenge in the industry.Meanwhile, the American Academy of Pediatrics has taken a cautious stance by not endorsing leucovorin for autism treatment due to insufficient evidence. This decision emphasizes the critical need for rigorous, evidence-based practices in developing clinical guidelines for complex disorders like autism.Internationally, CSL Seqirus has partnered with Saudi Arabia to supply cell-based influenza vaccines and support local production capabilities. This move aligns with global efforts to enhance pandemic preparedness and healthcare resilience through local manufacturing initiatives.The volatile nature of the biotech sector is evident with reports of 16 companies ceasing operations in 2025 due to high R&D costs and regulatory challenges. Despite these closures, such volatility opens doors for new innovations that could address unmet medical needs.Turning our attention to obesity treatment, Eli Lilly stands at a crucial juncture with its novel obesity medication, orforglipron. The company aims to make this weight loss pill accessible while maintaining financial viability for future R&D—a balancing act faced by many pharmaceutical companies as they strive to deliver affordable yet innovative treatments amid growing global health concerns. However, not all R&D efforts reach fruition. Eli Lilly has decided to discontinue its mid-stage program Support the show

SA approves HIV prevention injection : Health Minister Dr Aaron Motsoaledi by Radio Islam

In this episode, expert patient navigators Shellye Jones and Lauren Jackson discuss the key take-home points of our online educational program on facilitating engagement in HIV care and propose a framework for effectively retaining people in care. Topics covered include: How to approach a patient with complex barriers to engagement in healthcareResources for staying in care, such as wraparound servicesSetting SMART goals and formulating action plans with patientsDeconstructing stigma and implementing a trauma-informed approach to carePresenters:Shellye Jones, MSW, LCSWClinical SupervisorCharles R. Drew University, Drew CARESLos Angeles, CaliforniaLauren Harris JacksonStreet Medicine Patient NavigatorHealthcare in ActionLos Angeles, CaliforniaLink to full program: https://bit.ly/3Wh4Z1TGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In episode 59 of Going anti-Viral, Dr Demetre Daskalakis joins host Dr Michael Saag to discuss his career in public health and the turnover in leadership at the US Centers for Disease Control and Prevention (CDC). Dr Daskalakis is an infectious diseases physician who served in leadership roles at the CDC from 2020 to 2025. He was director of the National Center for Immunization and Respiratory Diseases and was previously director of the Division of HIV Prevention at the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. In 2022, he was appointed deputy coordinator of the White House response to the mpox outbreak. Dr Daskalakis discusses his career in public health and leadership roles in infectious diseases. Dr Saag and Dr Daskalakis have a detailed discussion about applying lessons learned from the HIV epidemic in the national response to the mpox outbreak and they discuss Dr Daskalakis's role at the CDC in response to the current measles outbreak. They also address ideologic-driven changes at the CDC under the direction of Secretary Robert F Kennedy Jr. and the Department of Health and Human Services including the firing of Dr Susan Monarez and Dr Daskalakis' subsequent resignation. Finally, they discuss the current direction of the CDC and the outlook for public health without scientific leadership. They also discuss the possibility of a renaissance for public health in the future where it can be reimagined to focus on people instead of historic funding paradigms. 0:00 – Introduction1:21 – Career path in public health and leadership in infectious diseases 4:01 – Applying lessons from the HIV epidemic in response to the mpox outbreak9:48 – Transition to CDC and challenges with the new administration13:50 – CDC role in response to the current measles outbreak17:45 – Management of the CDC by Secretary Robert F Kennedy Jr. and the Department of Health and Human Services 21:22 – The firing of Dr Susan Monarez from the CDC and Dr Daskalakis's resignation28:35 – The lack of scientific leadership remaining at CDC and future outlook ResourcesEpisode 50 - How Vaccines Get Approved in the US: The RSV Story and the Role of the ACIP – Dr Yvonne Maldonado__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

John Maytham speaks to Zano Kunene, journalist and author of the Bhekisisa feature, on how AI chatbots are reshaping HIV prevention and transforming the way young women in South Africa engage with sexual health. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

In this week's LGBTQ news: • Gay porn performer Austin Wolf sentenced to 19 years in prison • Republicans are seeking deep cuts to HIV prevention and treatment funding • An FBI agent fired for having a Pride flag on his desk • Madonna has penned a new song dedicated to her late brother • New music from out recording artist Milahroy - "Sleep In" All that and more in this episode of The Randy Report.

There are deep rumblings in the Part D prescription drug plan arena as the Feds have meddled in free market insurance market once too often.                            The plans are in trouble and those who need to rely on them for security are having difficulty. They need help figuring out how to arrange the most advantageous protection at the best available cost.                                                Soon, a newly discovered subscription service will help all who need it to fine-tune their prescription drug insurance. In the Medicare Advantage Minute segment, we review the article entitled:        "Are you unhappy with your MA plan? Here is some good news!" In the Your Medicare Advantage 2025 segment we find out whether Medicare will pay for Pre-Exposure Prophylaxis (PrEP) for HIV Prevention. Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; SIMPLEST & EASIEST GUIDE EVER!" "MEDICARE DRUG PLANS: A SIMPLE D-I-Y GUIDE" "MEDICARE FOR THE LAZY MAN: BARE BONES!" For sale on Amazon.com. After enjoying the books, please consider returning to leave a short customer review to  help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Planned Parenthood of Illinois is expanding its HIV prevention services to include a new long-acting medication that requires only two injections a year. The treatment, called Yeztugo, was recently approved by the U.S. Food and Drug Administration and is now available at all 13 Planned Parenthood health centers across the state.

Send us a textIn this episode, Mariah shares her journey with PrEP, discussing her experiences with HIV prevention, dating, and the stigma surrounding cisgender women's sexual health. She emphasizes the importance of empowerment through knowledge and access to resources like PrEP, while also addressing the challenges and barriers women face in advocating for their sexual health. Mariah highlights the need for open conversations about sexual health and the significance of community support in navigating these issues. She emphasizes that empowerment comes from taking control of one's sexual health and the fact that women often face more stigma in sexual health discussions than men.This episode was brought to you by The Los Angeles Family AIDS Network in collaboration with Reach LA.Support the showThis podcast is brought to you by the Los Angeles Family AIDS Network

In this special episode of the podcast, host Yvette Raphael and a panel of young female advocates take over the discussion at the IAS 2025 held in Kigali, Rwanda. The episode features insightful conversations with Sinehlanhla Gogela, Sihle Magwentshu, Siviwe Gaika, who are active members of the Young Women's HIV Prevention Council and ground forces with the organization APA. The panel discusses the impact of recent funding cuts on HIV prevention efforts, their experiences in promoting HIV awareness, and the importance of community engagement. They also highlight promising developments in HIV prevention, including the introduction of the long-lasting injectable Lenacapavir and the dual prevention pill (DPP). The advocates express their hopes for the future and the need for continued support and funding to sustain their vital work. 00:00 Introduction and Welcome 00:27 Meet the Guests 01:44 Impact of Funding Cuts 05:50 Conference Highlights and Key Takeaways 09:57 Future of HIV Prevention 16:30 The Role of Ground Forces 20:42 Closing Remarks and Celebrations

In this episode, host Ben Plumley, along with co-host Yvette Raphael, reports from the International AIDS Society Scientific Conference in Kigali, Rwanda. They discuss significant advancements in HIV prevention, particularly the recent FDA approval of Lenacapavir, with Dr. Alex Kintu from Gilead Sciences. The conversation covers the clinical journey and delivery mechanisms of Lenacapavir, its impact on young people and pregnant women, and the urgency of making this innovation widely accessible amidst funding challenges. The episode also highlights the critical role of community engagement and accountability boards in informing and driving HIV prevention strategies. Tune in for an in-depth look at the latest scientific and policy developments in the fight against HIV/AIDS. 00:00 Introduction and Welcome 00:37 Yvette's Stage Takeover Experience 01:33 Discussion on Gilead Sciences and HIV Prevention 02:15 Dr. Alex Kintu's Background and Role 03:33 FDA Approval and Next Steps for Lenacapavir 04:08 Global Access and Regulatory Processes 11:04 Understanding Lena Kavir and Its Importance 17:36 Challenges and Future of HIV Prevention 27:23 Community Engagement and Youth Involvement 34:33 Closing Remarks and Call to Action

Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this bi-annual injection could make in the fight against HIV.We hear how Malawi is trying to stop mpox from entering its borders. Reporter Carrim Mpaweni investigates the measures in place to keep the disease at bay.A skin swab test could detect Parkinson's disease 7 years ahead of symptoms developing. We find out how it's all thanks to a woman who can smell the disease.In the UK, Claudia meets the Cycling Together group which teaches women who are experiencing anxiety, depression or abusive relationships how to ride a bike. A woman in Guadeloupe went for a routine blood test and 15 years later discovers she has a unique blood type. But what does this mean for her health, and actually is a blood type anyway?Presenter: Claudia Hammond Producer: Hannah Robins Studio Managers: Searle Whittney and Neva Missirian

Drs. Anshel Kenkare and Mike Reid share a conversation about the incredible science and current context of lenacapavir for HIV prevention, which was recently approved by the FDA.Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.comFebrile is produced with support from the Infectious Diseases Society of America (IDSA)

Minoritea Report Ep 334 is serving wigs, tea, and unfiltered laughs! This week, Yo Aunteas dive into Brandy & Monica reuniting for The Boy Is Mine tour, Cardi B's fiery new single, and Chicago's O'Hare Airport possibly opening the first gay bar at a US airport. We spill on: The nostalgia and drama around the Brandy/Monica tour Cardi B's lines that have us shook Lizzo's rumored new single “We Outside” McDonald's DEI rollback and boycott talk Your Ask Yo Aunteas: F*ck Bud dilemmas So, get your cups ready for a Black queer perspective on pop culture, community news, and the hot mess in these streets with your favorite Aunteas.

On this week's Progress Report, Zachary and Emma spotlight the stories that prove the world is moving forward, from Ireland's bold move to end coal power to major U.S. brands ditching synthetic food dyes to breakthrough HIV prevention. They also cover how aviation safety is getting a high-tech upgrade as airlines roll out new cockpit alert systems that warn pilots about potential runway mix-ups and risky landings. Last, tune in to see if they stick the landing after a diversion into a joke from a problematic comedian. What Could Go Right? is produced by The Progress Network and The Podglomerate. For transcripts, to join the newsletter, and for more information, visit: theprogressnetwork.org Watch the podcast on YouTube: ⁠⁠⁠https://www.youtube.com/theprogressnetwork⁠⁠⁠ And follow us on X, Instagram, Facebook, TikTok: @progressntwrk Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA approved lenacapavir, a twice-yearly injectable PrEP shown to be 99% effective in preventing HIV, though high cost may limit global access. A phase 3 trial found that adding pembrolizumab to standard care improved event-free survival in head and neck cancer, especially in patients with high PD-L1 expression. MASLD-related deaths in the U.S. have quadrupled since 2006, rising most sharply in older adults and rural areas, and are expected to continue increasing.

Natalie Fleet is the Labour MP for Bolsover whose path into politics has been far from typical. From a very young age, teachers told her she was destined for university – something almost unheard of in her Nottingham mining town. But her future took a different turn, when at fifteen, she became pregnant by an older man. At the time she had thought they were in a relationship - but as she grew older, Natalie says she realised she had been a victim of grooming and statutory rape. She's now speaking out to give a voice to those she feels have been made to feel they should be silent, and joins Anita Rani in the studio. Only 3.1% of PREP users in England are women. That's Pre-Exposure Prophylaxis, a drug that reduces the risk of being infected with HIV. Many women don't know that PREP exists, or don't consider themselves at risk. Yet women accounted for 30% of new HIV diagnoses in England in 2023. This week, the Elton John AIDS Foundation has launched pilot programmes to increase women's access to PREP. Anita was joined by Dr Jenny Whetham, Consultant and Joint Clinical Lead, Sexual Health and HIV Medicine, Brighton and Anne Aslett, CEO of the Elton John AIDS Foundation to discuss.Trisha Goddard rose to fame as a TV journalist. She was the first black TV presenter in Australia and is best known in the UK for her eponymous TV show which aired on ITV and Channel 5 in the late 90s and 2000s, earning her a reputation as the British Oprah. She joined Anita to talk about her career, appearing on Celebrity Big Brother and why she chose recently to go public with her diagnosis for stage 4 metastatic breast cancer.BBC journalist Sanchia Berg and fertility lawyer Beverley Addison joined Nuala McGovern to discuss the recent cases of older couples becoming parents via surrogacy.Comedian, actor and writer Rosie Jones joined Nuala to discuss her first sitcom, Pushers, which she stars in and co-wrote. She plays Emily in the Channel 4 show, who has very little left to lose after having her disability benefits cut when she loses her job - she finds herself building an illegal drugs empire. Emily isn't your average street-dealer though - she's sharp, funny, highly educated and has cerebral palsy. What better disguise could there be for criminal activity than to be entirely written off by society?Presenter: Anita Rani Producer: Annette Wells Editor: Rebecca Myatt

Trisha Goddard rose to fame as a TV journalist. She was the first black TV presenter in Australia and is best known in the UK for her eponymous TV show which aired on ITV and Channel 5 in the late 90s and 2000s, earning her a reputation as the British Oprah. She joins Anita to talk about her career, appearing on Celebrity Big Brother and why she chose recently to go public with her diagnosis for stage 4 metastatic breast cancer.Air pollution kills more than 500 people a week in the UK and costs more than 500 million pounds a week in ill health, according to a new report, "A breath of fresh air," by the Royal College of Physicians. The report highlights growing evidence about health issues linked to toxic air and calls it “a public health crisis”. Today, a group of doctors, nurses and campaigners are walking from Great Ormond Street Hospital to Downing Street with a letter calling on government ministers to commit to more ambitious air quality targets. Anita talks to two of them, Rosamund Kissi Debrah, whose daughter Ella became the first person in the UK to have air pollution cited on their death certificate and Professor Sir Stephen Holgate, co author of today's report.Only 3.1% of PREP users in England are women. That's Pre-Exposure Prophylaxis, a drug that reduces the risk of being infected with HIV. Many women don't know that PREP exists, or don't consider themselves at risk. Yet women accounted for 30% of new HIV diagnoses in England in 2023. Today, the Elton John AIDS Foundation is launching pilot programmes to increase women's access to PREP. Anita is joined by Dr Jenny Whetham, Consultant and Joint Clinical Lead, Sexual Health and HIV Medicine, Brighton and Anne Aslett, CEO of the Elton John AIDS FoundationThe clever one. The funny one. The beautiful one. But which one is The Favourite? Set over a single week, but examining the highs and lows that define a family over the decades, this book is a story of rivalries and long-held resentments, about loss and grief and blame – and love. Fran Littlewood – also author of New York Times bestseller Amazing Grace Adams talks to Anita about her new novel.Presenter: Anita Rani Producer: Rebecca Myatt

In this episode, Dr. June Gipson, CEO of My Brother's Keeper, Inc., joins the podcast to share how her organization is addressing sexual and reproductive health, tackling funding cuts, and expanding care across Mississippi. She also discusses emerging public health trends, the power of prevention, and how leaders must adapt to sustain impact in fragile systems.

Welcome to The Monday Edit! This is the official Getting Better companion podcast where JVN and senior producer Chris are diving into all things BTS from the pod, answering listener questions, and breaking down the world at large. This week, we're talking: astrological sister signs, the ongoing Bhad Bhabie & Alabama Barker feud, the great Cybertruck recall of 2025, and the recent attacks on the HIV social safety net. We're giving you laughs and learning over here - plus: Full video episodes now on YouTube every Monday!  Follow us on Instagram @gettingbetterwithjvn Jonathan on Instagram @jvn and senior producer Chris @amomentlikechris New video episodes of Getting Better on YouTube every Wednesday. Our Senior Producer is Chris McClure. Our editor & engineer is Nathanael McClure. Our theme music is also composed by Nathanael McClure. Production support from Julie Carrillo, Anne Currie, and Chad Hall. Curious about bringing your brand to life on the show? Email podcastadsales@sonymusic.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Abdul and Katelyn talk about a promising bipartisan bill that could disrupt Pharmacy Benefit Managers, a miracle drug that prevents HIV--at a serious cost, and new data that show that US obesity rates may have fallen for the first time in more than a decade. Then they talk about RFK Jr's chances of being confirmed to lead HHS after news broke last week that his attorney asked the FDA to repeal approval of the polio vaccine back in 2022. Then Abdul sits down with Dr. Umair Shah, Washington State's Secretary of Health, about the role of state health departments over the next four years. We will be back with more episodes in 2025. We wish you all a restful holiday season!  This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: Marguerite Casey Foundation: Sign up now to get your free Boston Review issue delivered to your door at CaseyGrants.org/State. Calm: Calm is offering an exclusive offer of 40% off a Calm Premium Subscription at calm.com/DISSECT. Lumen: If you want to stay on track with your health this holiday season, head to http://lumen.me/AD for 15% off your purchase. Reclaimed: This podcast takes you back to the very beginning when the Navajo reservation was first created. And it reveals the history of oppression and exclusion that led the Navajo to this point — and why their future is still uncertain. You can listen to “Reclaimed” wherever you get podcasts.